Latest News & Features
article
With the two-year Brexit negotiations underway, life sciences companies and their lawyers will be watching closely to see how their businesses and IP will be affected. LSIPR reports with views from the UK, France and Germany. 10 July 2017
Sectors
With legal developments in the CRISPR field ramping up this year, LSIPR examines the current international landscape and the options for parties interested in using the gene-editing technology. 9 July 2017
Big Pharma
The products made by GQ Life Sciences, based in Boston, make IP-related sequence searching easier for scientists, patent searchers and practitioners, as senior product manager Ellen Sherin tells LSIPR. 8 July 2017
Big Pharma
The UK Supreme Court has ruled that Actavis’s generic versions of cancer drug Alimta directly infringe patents owned by Eli Lilly, reversing two earlier decisions. 7 July 2017
Europe
Biotech company Silence Therapeutics has filed a case on supplementary protection certificates at the English Patents Court against Alnylam and The Medicines Company. 7 July 2017
Big Pharma
The European Commission has sent statements of objections to Merck and Sigma-Aldrich, stating that it has concerns regarding their merger in 2015. 6 July 2017
Biotechnology
More than 120 tons of counterfeit pesticides have been seized during an operation by Europol. 6 July 2017
Big Pharma
GSK has entered into a strategic drug discovery collaboration with an artificial intelligence-driven drug discovery company, Exscientia. 5 July 2017
Americas
Medical device company OrthoAccel Technologies has filed a complaint against Propel Orthodontics for patent infringement. 5 July 2017
Europe
The English High Court is seeking answers from the CJEU on aspects of the EU’s regulation on supplementary protection certificates, but it’s possible questions will remain following the rulings. Michael Pears and Joel Beevers of Potter Clarkson report. 5 July 2017